Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03261700 · ClinicalTrials.gov registry record · NA

Recovering From Intimate Partner Violence Through Strengths and Empowerment (RISE)

A NA study of Self Efficacy and Intimate Partner Violence, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT03261700: Completed NA study of Self Efficacy and Intimate Partner Violence, sponsored by VA Office of Research and Development.

NCT03261700 is a NA study of Self Efficacy and Intimate Partner Violence that has completed, run by VA Office of Research and Development. The registered enrollment target is 60 participants, below the 152-participant average among 30 other Self Efficacy trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03261700, a NA study of Self Efficacy and Intimate Partner Violence, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Intimate partner violence (IPV) is a major health concern for women Veterans. IPV is associated with numerous physical and mental health conditions. VHA is implementing IPV screening programs to identify female patients who experience past-year IPV. Despite strong evidence that screening increases detection of IPV, less is established about how to intervene following IPV disclosure in health care settings, in order to improve health outcomes. Existing healthcare-based interventions result in minimal effects on health and well-being, likely because they are too brief and generic. In response, the PI has developed Recovering from IPV through Strengths and Empowerment (RISE), based on the IPV-related health care needs and preferences of women Veterans. RISE is designed to be delivered in primary care and is an individualized, variable-length, modular-based intervention that addresses * safety planning; * education on the health effects of IPV and warning signs; * increasing coping skills and self-care; * enhancing social support; * making difficult decisions; and * connecting with resources. This study is aimed at refining and evaluating RISE for use with female VA patients who have experienced past-year IPV. This brief counseling intervention is intended to be administered in conjunction with primary care, as this is a frequent point of healthcare contact for women Veterans and where disclosure of IPV is most prevalent.

Primary Outcome

Measures change in sense of personal empowerment; minimum value = 28 and maximum score = 196; higher scores indicate higher personal empowerment

Interventions

  • BEHAVIORAL RISE
  • OTHER Information and referral condition

Study Locations (1)

Massachusetts

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2018-10-22
Est. Completion 2020-11-23
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT03261700 record still lists

NCT03261700 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 152-participant average among 30 other Self Efficacy trials with a reported enrollment target (61% lower).

The record links to 2 conditions, with Self Efficacy appearing as the primary indexed condition, and to 2 interventions - of which RISE is the first listed.

NCT03261700 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03261700 about?

NCT03261700 is a clinical study titled "Recovering From Intimate Partner Violence Through Strengths and Empowerment (RISE)". Intimate partner violence (IPV) is a major health concern for women Veterans. IPV is associated with numerous physical and mental health conditions. VHA is implementing IPV screening programs to identify female patients who experience past-year IPV. Despite strong evidence that screening increases d...

What is the current status of trial NCT03261700?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-10-22. Estimated completion is 2020-11-23.

What conditions does trial NCT03261700 study?

This clinical trial studies the following conditions: Self Efficacy, Intimate Partner Violence.

What interventions are being tested in trial NCT03261700?

The interventions under investigation include: RISE (BEHAVIORAL), Information and referral condition (OTHER).

Who is sponsoring clinical trial NCT03261700?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03261700 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Self Efficacy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03261700's enrollment target sits among peer trials

60 22nd of 30 higher than 8 of 30 other Self Efficacy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Self Efficacy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03261700, the US trial registry maintained by the National Library of Medicine. NCT03261700 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.